Clinical Trial Update: Omega-3 Dietary Supplements in Schizophrenia [NA]

View source ↗

Summary

The clinical trial evaluating omega-3 dietary supplements for schizophrenia has completed and its results were posted in February 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia
• Schizophreniform Disorder

Drugs mentioned

• Omega-3 dietary supplements (omega-3 fatty acids)

Snippet

Sponsor: Delbert Robinson | Conditions: Schizophrenia, Schizophreniform Disorder | NA | Status: COMPLETED | Results posted: 2017-02-01